Trial Profile

Development of Ibudilast as a Novel Treatment for Alcohol Dependence

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 07 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ibudilast (Primary)
Indications Alcoholism
Focus Therapeutic Use

Most Recent Events

23 Jan 2017 Results published in the Media Release
23 Jan 2017 According to a MediciNova media release, results from this study were published in the medical journal Neuropsychopharmacology
29 Jun 2016 According to a MediciNova media release, results from this study were presented at the 39th Annual Scientific Meeting of the Research Society on Alcoholism.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com